It is clear that CVS understands the importance of keeping up with the demand for consumer healthcare. CVS made an announcement earlier this month that they would officially start offering CBD products derived from industrial hemp in stores across eight states. This is a bold move that is showing how the public favours CBD. It also shows that corporate America is starting to pay attention. CVS told NBC News that CBD products such as creams, salves, lotions, roll-ons, and sprays would be marketed as “an alternative source of relief.”
CVS retail locations in Tennessee, California, Indiana, Kentucky, Maryland, Colorado, Illinois, and others are all set to start offering CBD products in an estimated 800 CVS stores encompassing 10 states.
The Legality Of Things
There are currently clouds of confusion surrounding CBD legality in the United States thanks to the confusing federal government. When CBD from industrial hemp was removed from the controlled substance act with the signing of the 2018 Farm Bill, many people believe that CBD, as long as it came from industrial hemp, would be completely legal. However, this is not the case as we saw with the recent raids in states nationwide on entities offering hemp derived CBD products.
It will be interesting to see how the sales of CBD take off at CVS locations. If sales are successful, there is a chance that CBD will soon be available in all CVS locations nationwide. This could in return lead to more reputable companies and drug stores offering CBD products in the coming years. Hopefully, CVS will not face the same scrutiny that many other entities have faced by offering CBD products such as raids by the state or federal government.
Curaleaf Products To Be Offered In CVS Locations
The products that will be available at CVS locations will be through a partnership with Curaleaf. Curaleaf hemp lotions and transdermal patches are among some of the products that will be available in these locations.
Curaleaf is a reputable name in the cannabis sector. According to Green Entrepreneur Curaleaf operates in “12 states with 42 dispensaries, 12 cultivation sites, and 11 processing sites.” Curaleaf is also trading publicly on the Canadian Securities Exchange under the stock ticker CURA.
According to the CEO of Curaleaf, “All large retailers are figuring out their hemp strategy and will address that in 2019 because there is such a huge product demand.” This solidifies the thought that one day, very soon, CBD will be available in various major retailers nationwide.